Physician profile
Daniel J Lee
NPI 1437130267
$52,129.92
in general payments reported to CMS, 2019-2025
10 companies · $12K in 2025
The $12K reported for 2025 was more than what 97% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $288 · 2020: $4,088 · 2021: $11K · 2022: $37.12 · 2023: $19K · 2024: $5,929 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Grant: $10K · Travel and Lodging: $3,915 · Food and Beverage: $469 · Education: $9.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,723.50 |
| Grant | $10,000.00 |
| Travel and Lodging | $3,915.34 |
| Food and Beverage | $468.95 |
| Education | $9.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| 3nt Medical | $35,711.00 | 2020-2025 | Peregrine Drivable Ent Scope, Colibri Micro Ent Scope |
| Med-El Corporation | $15,929.01 | 2024-2025 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit, Adhear Professional Kit |
| Grace Medical, INC. | $146.59 | 2023 | |
| Medtronic Vascular, INC. | $127.00 | 2019 | |
| Karl Storz Endoscopy-America | $119.80 | 2019 | |
| Advanced Bionics, LLC | $37.12 | 2022 | |
| Acclarent, INC | $30.00 | 2019 | |
| Depuy Synthes Sales INC. | $18.44 | 2023 | Teligen |
| Covidien Lp | $10.96 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$25,780.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.